A phase II clinical trial to analyze olaparib response in patients with BRCA1 and/or BRCA2 promoter methylation with advanced breast cancer (GEICAM/2015-06 COMETA-Breast study).

被引：5

作者：

De La Haba, Juan

Guerrero-Zotano, Angel

Alejandro Perez-Fidalgo, Jose

Gonzalez Santiago, Santiago

Munoz, Montserrat

Andres, Raquel

Cruz Zambrano, Cristina

Moran Salama, Sebastian

Lopez-Tarruella, Sara

Quiroga Garcia, Vanesa

Servitja, Sonia

Mele, Mireia

Alonso Soler, Sonia

Adamo, Barbara

Jose Escudero, Maria

Martin, Nuria

Bezares, Susana

Caballero, Rosalia

Esteller, Manel

Rojo, Federico

机构：

[1] Univ Cordoba, Biomed Res Inst Maimonides, Hosp Univ Reina Sofia, Cordoba, Spain

[2] Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII, GEICAM, Cordoba, Spain

[3] Inst Valenciano Oncol, GEICAM Spanish Breast Canc Grp, Valencia, Spain

[4] Hosp Clin Univ Valencia, Valencia, Spain

[5] INCLIVA, Valencia, Spain

[6] Ctr Invest Biomed Red Oncol, Valencia, Spain

[7] CIBERONC ISCIII, Valencia, Spain

[8] GEICAM Spanish Breast Canc Grp, Valencia, Spain

[9] Complejo Hosp Univ Caceres Spain, Caceres, Spain

[10] GEICAM Spanish Breast Canc Grp, Caceres, Spain

[11] Hosp Clin Barcelona, Barcelona, Spain

[12] Inst Invest Biomed Pi & Sunyer IDIBAPS, Barcelona, Spain

[13] GEICAM Spanish Breast Canc Grp, Barcelona, Spain

[14] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[15] GEICAM Spanish Breast Canc Grp, Zaragoza, Spain

[16] GEICAM Spanish Breast Canc Grp, Vall DHebron Inst Oncol VHIO, Barcelona, Spain

[17] Bellvitge Biomed Res Inst, Barcelona, Spain

[18] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain

[19] Ctr Invest Biomed Red Oncol, Madrid, Spain

[20] CIBERONC ISCIII, Madrid, Spain

[21] GEICAM Spanish Breast Canc Grp, Madrid, Spain

[22] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Dept Med Oncol, Badalona, Spain

[23] Hosp Mar Med Res Inst IMIM, Barcelona, Spain

[24] Ctr Invest Biomed Red Oncol, Barcelona, Spain

[25] CIBERONC ISCIII, Barcelona, Spain

[26] GEICAM Spanish Breast Canc Grp, Barcelona, Spain

[27] Univ Rovira & Virgili, Hosp Univ St Joan de Reus, Inst Oncol Catalunya Sud IOCS, Canc Genet Counseling Unit,Oncol Res Grp, Reus, Spain

[28] Complejo Hosp Univ Caceres, Caceres, Spain

[29] GEICAM Spanish Breast Canc Grp, Caceres, Spain

[30] Hosp Clin Barcelona, Barcelona, Spain

[31] Inst Invest Biomed Pi & Sunyer IDIBAPS, Barcelona, Spain

[32] GEICAM Spanish Breast Canc Grp, Barcelona, Spain

[33] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Barcelona, Spain

[34] Fdn Jimenez Diaz, Madrid, Spain

[35] CIBERONC ISCIII, Ctr Invest Biomed Red Oncol, Madrid, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.TPS1114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS1114

引用

页数：1